Study to Assess the Absorption, Metabolism and Excretion of \[14C\] NKTR-118 after a Single-Dose Oral Administration.
Study Type
INTERVENTIONAL
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
6
Single 25 mg oral dose administered on Day 1
Research Site
London, United Kingdom
Percentage of radioactive dose recovered in urine and feces samples and the total percentage of radioactive dose recovered in both urine and feces
Time frame: Range of Day 1 until day 10
Concentration of total radioactivity in blood and plasma samples
Time frame: Range of Day 1 until day 10
Concentration of NKTR-118 in blood and plasma sample
Time frame: Range of Day 1 until day 10
Safety and tolerability of NKTR-118 following administration of a single oral dose of [14] NKTR-118 solution by assessing adverse event
Time frame: Range of Day -1 until follow up visit (Visit 3)
Safety and tolerability of NKTR-118 following administration of a single oral dose of [14] NKTR-118 solution by assessing vital signs
Time frame: Range of Day -1 until follow up visit (Visit 3)
Safety and tolerability of NKTR-118 following administration of a single oral dose of [14] NKTR-118 solution by assessing safety blood samples
Time frame: Range of Day -1 until follow up visit (Visit 3)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.